Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC
Accepted 2022-04-29 00:00:00 ET · period of report 2022-03-16 · accession 0001209191-22-026140 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-29 | 2022-03-16 | CPIX | Hamm John M. | CFO | A - Grant | $2.59 | +20.0K | 26.8K | +294% | +$51.8K |
| D | 2022-04-29 | 2022-03-16 | CPIX | Hamm John M. | CFO | A - Grant | $0.00 | +2,000 | 2,000 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-16 | A | A | 20,000 | $2.59 | 26,800 | D | — | — | (F1) 100% vesting on March 16, 2025. |
| 2 | Derivative | Options (right to buy) | 2022-03-16 | A | A | 2,000 | $0.00 | 2,000 | D | $2.59 · 2026-03-16 to 2032-03-16 | 2,000 Common Stock | (F2) 100% vesting on March 16, 2026. |